Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance.
暂无分享,去创建一个
P. Abbe | C. Bertolotto | R. Ballotti | C. Robert | S. Moréra | L. Héliot | S. Rocchi | P. Gual | P. Hofman | B. Mograbi | A. Vigouroux | Anne-Sophie Dabert-Gay | D. Debayle | D. Alcor | Maruf M. U. Ali | R. Benhida | V. Hofman | M. Plaisant | J. Annicotte | T. Botton | T. Passeron | C. Ronco | A. Millet | Michaël Cerezo | Nabil Rabhi | A. Lehraiki | Florian Rouaud | Emilie Jaune | Hella Amdouni | Mariano Gonzalez-Pisfil | Abdelali Lehraiki
[1] G. Kaushik,et al. Honokiol inhibits melanoma stem cells by targeting notch signaling , 2015, Molecular carcinogenesis.
[2] B. Su,et al. MDA-9 and GRP78 as potential diagnostic biomarkers for early detection of melanoma metastasis , 2015, Tumor Biology.
[3] G. Kaushik,et al. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway. , 2014, American journal of surgery.
[4] J. Bussink,et al. The unfolded protein response as a target for cancer therapy. , 2014, Biochimica et biophysica acta.
[5] P. Abbe,et al. Preview : Published ahead of advance online publication Inhibition of Melanogenesis by the Antidiabetic Metformin , 2014 .
[6] A. Eggermont,et al. eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies , 2014, Nature.
[7] M. Herlyn,et al. Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. , 2014, The Journal of clinical investigation.
[8] S. Shenolikar. Dangerous liaisons: flirtations between oncogenic BRAF and GRP78 in drug-resistant melanomas. , 2014, The Journal of clinical investigation.
[9] G. Garçon,et al. Mitochondrial oxidative stress is the achille's heel of melanoma cells resistant to Braf-mutant inhibitor , 2013, Oncotarget.
[10] B. Lefkove,et al. Inducing apoptosis of cancer cells using small-molecule plant compounds that bind to GRP78 , 2013, British Journal of Cancer.
[11] P. Abbe,et al. Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner , 2013, Molecular Cancer Therapeutics.
[12] C. Goding. The path of least resistance: enhancing the effectiveness of BRAF inhibitors , 2013, Pigment cell & melanoma research.
[13] P. Lambin,et al. PERK/eIF2α signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS , 2013, Proceedings of the National Academy of Sciences.
[14] Afshin Samali,et al. New directions in ER stress-induced cell death , 2013, Apoptosis.
[15] D. Maddalo,et al. The Molecular Chaperone GRP78/BiP in the Development of Chemoresistance: Mechanism and Possible Treatment , 2013, Front. Pharmacol..
[16] K. Flaherty,et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. , 2012, The New England journal of medicine.
[17] Y Usson,et al. Generalization of the polar representation in time domain fluorescence lifetime imaging microscopy for biological applications: practical implementation , 2012, Journal of microscopy.
[18] Zongwei Li,et al. Glucose regulated protein 78: a critical link between tumor microenvironment and cancer hallmarks. , 2012, Biochimica et biophysica acta.
[19] Robert Clarke,et al. Guidelines for the use and interpretation of assays for monitoring autophagy , 2012 .
[20] S. Shankar,et al. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. , 2011, Biochemical pharmacology.
[21] P. Bahadoran,et al. Metformin inhibits melanoma development through autophagy and apoptosis mechanisms , 2011, Cell Death and Disease.
[22] A. Aplin,et al. Mechanisms of resistance to RAF inhibitors in melanoma , 2011, The Journal of investigative dermatology.
[23] Y. Usson,et al. Quantitative comparison of polar approach versus fitting method in time domain FLIM image analysis , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[24] J. Ortonne,et al. Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth , 2011, Cell Death and Differentiation.
[25] K. Flaherty,et al. Inhibition of mutated, activated BRAF in metastatic melanoma. , 2010, The New England journal of medicine.
[26] Marek Michalak,et al. Quality control in the endoplasmic reticulum. , 2010, Seminars in cell & developmental biology.
[27] Shing-Hwa Liu,et al. Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress. , 2010, Cancer letters.
[28] Philippe Lambin,et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. , 2010, The Journal of clinical investigation.
[29] K. Smalley. Understanding melanoma signaling networks as the basis for molecular targeted therapy. , 2010, The Journal of investigative dermatology.
[30] C. Spriet,et al. Three‐dimensional polar representation for multispectral fluorescence lifetime imaging microscopy , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[31] V. Sondak,et al. Targeted therapy in melanoma. , 2013, Clinics in dermatology.
[32] E. Morselli,et al. Anti- and pro-tumor functions of autophagy. , 2009, Biochimica et biophysica acta.
[33] C. Spriet,et al. Optimized protocol of a frequency domain fluorescence lifetime imaging microscope for FRET measurements , 2009, Microscopy research and technique.
[34] P. Bahadoran,et al. In vitro and in vivo anti-melanoma effects of ciglitazone. , 2009, The Journal of investigative dermatology.
[35] R. Scolyer,et al. Expression of glucose‐regulated stress protein GRP78 is related to progression of melanoma , 2009, Histopathology.
[36] P. Codogno,et al. Does autophagy have a license to kill mammalian cells? , 2009, Cell Death and Differentiation.
[37] F. Rizzi,et al. Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[38] G. Shore,et al. The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family , 2008, Oncogene.
[39] H. Mukhtar,et al. Multitargeted therapy of cancer by green tea polyphenols. , 2008, Cancer letters.
[40] E. Gratton,et al. The phasor approach to fluorescence lifetime imaging analysis. , 2008, Biophysical journal.
[41] M. Jäättelä,et al. Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium , 2007, Cell Death and Differentiation.
[42] Amy S. Lee. GRP78 induction in cancer: therapeutic and prognostic implications. , 2007, Cancer research.
[43] Afshin Samali,et al. Mediators of endoplasmic reticulum stress‐induced apoptosis , 2006, EMBO reports.
[44] M. Demierre. Epidemiology and prevention of cutaneous melanoma , 2006, Current treatment options in oncology.
[45] F. Waharte,et al. Setup and characterization of a multiphoton FLIM instrument for protein–protein interaction measurements in living cells , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[46] P. Codogno,et al. Regulation and role of autophagy in mammalian cells. , 2004, The international journal of biochemistry & cell biology.
[47] I. Braakman,et al. Quality control in the endoplasmic reticulum protein factory , 2003, Nature.
[48] J Auwerx,et al. PPARgamma, the ultimate thrifty gene. , 1999, Diabetologia.
[49] J C Briggs,et al. Cutaneous melanoma. , 1993, Journal of the American Academy of Dermatology.
[50] B. Thiers. Immunotherapy of malignant melanoma. , 1982, Journal of the American Academy of Dermatology.
[51] A. Chadli. THE CANCER CELL , 1924, La Presse medicale.